Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kinetics of circulating proteasome during bortezomib (Velcade) treatment in multiple myeloma
2008-005905-21Phase 3Terminated
- Sponsor
- CHU Nîmes
- Start
- Mar 2009
- Modality
- Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of bortezomib in multiple myeloma (MM), sponsored by CHU Nîmes. Started Mar 2009; status: terminated.
02
Drugs
bortezomib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on 2008-005905-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005905-21.